Peptide record

TPDB24294

ATN-161 Antibacterial Antiviral Tumor-homing Peptides modified_plain modified
5 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB24294
ATN-161
Antibacterial Antiviral Tumor-homing Peptides
Anti-infective peptides Cancer-related peptides
Peptipedia dbAMP 3.0 DRAMP DRAVP 2.0 TumorHoPe2.0
modified_plain
Yes
A 5-aa modified multi-activity (Antibacterial, Antiviral, and Tumor-homing Peptides) peptide sequence curated from Peptipedia, dbAMP 3.0, DRAMP, and other sources, with an available 3D structural model.
C-terminal: amide group (-NH2) N-terminal: N-acetyl group
Sequence
PHSCN
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
5 reviewed residue count
amide group (-NH2) Activity
NGR, APRPG, RGD Activity
N-acetyl group Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Tumor-homing Peptides

Target

Tumor cell, endothelial cell
Homing
Melanoma cancer
α5β1

Source & Reference

TumorHoPe2.0
TumorHoPe2
Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma
2012
Wenbing Dai et al. Nanomedicine. 2012 Oct 8(7):1152-61.

Other

Source Activity Label Source Definition
Tumor-homing Peptides
TumorHoPe2.0 experimentally validated tumor-homing peptide annotation.
murine melanoma cells B16F10 , human breast cancer cell MDA-MB-231
Male C57BL/6 mice (6 to 8 weeks old, body weight of 18 to 22 g)
DOX(doxorubicin)-loaded PEGylated liposomes
Additional Detail Fields 3 fields
DOX(doxorubicin)-loaded PEGylated liposomes
murine melanoma cells B16F10 , human breast cancer cell MDA-MB-231
Male C57BL/6 mice (6 to 8 weeks old, body weight of 18 to 22 g)